The Fragility of Statistically Significant Binary Outcomes for Treating Achilles Tendinopathy: A Systematic Review of Randomized Trials
Background: Randomized controlled trials (RCTs) are the gold standard for treatment efficacy, but foot and ankle RCTs are often small or inconsistent. The Fragility Index (FI) evaluates the stability of significant findings. This study assessed the fragility of RCT outcomes for Achilles tendon patho...
        Saved in:
      
    
          | Main Authors: | , , , , , | 
|---|---|
| Format: | Article | 
| Language: | English | 
| Published: | SAGE Publishing
    
        2024-11-01 | 
| Series: | Foot & Ankle Orthopaedics | 
| Online Access: | https://doi.org/10.1177/24730114241300160 | 
| Tags: | Add Tag 
      No Tags, Be the first to tag this record!
   | 
| _version_ | 1846161428148387840 | 
|---|---|
| author | Omkar S. Anaspure BA Shiv Patel BA Anthony N. Baumann DPT Andrew Newsom BS Albert T. Anastasio MD Annunziato Amendola MD | 
| author_facet | Omkar S. Anaspure BA Shiv Patel BA Anthony N. Baumann DPT Andrew Newsom BS Albert T. Anastasio MD Annunziato Amendola MD | 
| author_sort | Omkar S. Anaspure BA | 
| collection | DOAJ | 
| description | Background: Randomized controlled trials (RCTs) are the gold standard for treatment efficacy, but foot and ankle RCTs are often small or inconsistent. The Fragility Index (FI) evaluates the stability of significant findings. This study assessed the fragility of RCT outcomes for Achilles tendon pathology (ATP) interventions. Methods: This systematic review queried PubMed up to May 14, 2024, for RCTs on ATP interventions. RCTs with significant binary outcomes were included. Two reviewers assessed eligibility, extracted data, calculated FIs, and evaluated risk of bias. Frequency-weighted means were used for narrative synthesis. Results: Eleven RCTs with 4506 patients (mean cohort size: 409.64 ± 160.54) and a mean age of 36.97 ± 13.51 years (n = 4356; 96.67%) were included, covering 24 binary outcomes. The median FI across all outcomes was 3 (interquartile range 1-4; mean 3.92), indicating that changing the outcome of just a few patients could shift a study’s results from statistically significant to nonsignificant. Trials having an FI ≤3 comprised 58.33%. Three outcomes (12.5%) had an FI of zero after recalculating P values using the two-sided Fisher exact test. Half of the outcomes were robust. No RCT reported FIs or adjusted significance for multiple testing. Most studies (81.82%) performed 2 or more statistical tests, with an average of 30.81 ± 41.28 P values reported per study. The overall risk of bias was low in 1 study (9.09%) and moderate in 7 (63.64%). Most studies had low risk of bias in randomization (72.73%) and missing outcome data (90.91%). Conclusion: The FI assesses the fragility of statistically significant binary results, revealing that many ATP RCTs have fragile outcomes due to small sample sizes. A median FI of 3 means that changing the outcome of 3 patients could shift a study’s results from statistically significant to nonsignificant. | 
| format | Article | 
| id | doaj-art-cebd0cf9beff4f0b990b906a8f4999cf | 
| institution | Kabale University | 
| issn | 2473-0114 | 
| language | English | 
| publishDate | 2024-11-01 | 
| publisher | SAGE Publishing | 
| record_format | Article | 
| series | Foot & Ankle Orthopaedics | 
| spelling | doaj-art-cebd0cf9beff4f0b990b906a8f4999cf2024-11-21T08:06:21ZengSAGE PublishingFoot & Ankle Orthopaedics2473-01142024-11-01910.1177/24730114241300160The Fragility of Statistically Significant Binary Outcomes for Treating Achilles Tendinopathy: A Systematic Review of Randomized TrialsOmkar S. Anaspure BA0Shiv Patel BA1Anthony N. Baumann DPT2Andrew Newsom BS3Albert T. Anastasio MD4Annunziato Amendola MD5Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USAPerelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USADepartment of Rehabilitation Services, University Hospitals, Cleveland, OH, USACollege of Medicine, Northeast Ohio Medical University, Rootstown, OH, USADepartment Orthopedic Surgery, Duke University, Durham, NC, USADepartment Orthopedic Surgery, Duke University, Durham, NC, USABackground: Randomized controlled trials (RCTs) are the gold standard for treatment efficacy, but foot and ankle RCTs are often small or inconsistent. The Fragility Index (FI) evaluates the stability of significant findings. This study assessed the fragility of RCT outcomes for Achilles tendon pathology (ATP) interventions. Methods: This systematic review queried PubMed up to May 14, 2024, for RCTs on ATP interventions. RCTs with significant binary outcomes were included. Two reviewers assessed eligibility, extracted data, calculated FIs, and evaluated risk of bias. Frequency-weighted means were used for narrative synthesis. Results: Eleven RCTs with 4506 patients (mean cohort size: 409.64 ± 160.54) and a mean age of 36.97 ± 13.51 years (n = 4356; 96.67%) were included, covering 24 binary outcomes. The median FI across all outcomes was 3 (interquartile range 1-4; mean 3.92), indicating that changing the outcome of just a few patients could shift a study’s results from statistically significant to nonsignificant. Trials having an FI ≤3 comprised 58.33%. Three outcomes (12.5%) had an FI of zero after recalculating P values using the two-sided Fisher exact test. Half of the outcomes were robust. No RCT reported FIs or adjusted significance for multiple testing. Most studies (81.82%) performed 2 or more statistical tests, with an average of 30.81 ± 41.28 P values reported per study. The overall risk of bias was low in 1 study (9.09%) and moderate in 7 (63.64%). Most studies had low risk of bias in randomization (72.73%) and missing outcome data (90.91%). Conclusion: The FI assesses the fragility of statistically significant binary results, revealing that many ATP RCTs have fragile outcomes due to small sample sizes. A median FI of 3 means that changing the outcome of 3 patients could shift a study’s results from statistically significant to nonsignificant.https://doi.org/10.1177/24730114241300160 | 
| spellingShingle | Omkar S. Anaspure BA Shiv Patel BA Anthony N. Baumann DPT Andrew Newsom BS Albert T. Anastasio MD Annunziato Amendola MD The Fragility of Statistically Significant Binary Outcomes for Treating Achilles Tendinopathy: A Systematic Review of Randomized Trials Foot & Ankle Orthopaedics | 
| title | The Fragility of Statistically Significant Binary Outcomes for Treating Achilles Tendinopathy: A Systematic Review of Randomized Trials | 
| title_full | The Fragility of Statistically Significant Binary Outcomes for Treating Achilles Tendinopathy: A Systematic Review of Randomized Trials | 
| title_fullStr | The Fragility of Statistically Significant Binary Outcomes for Treating Achilles Tendinopathy: A Systematic Review of Randomized Trials | 
| title_full_unstemmed | The Fragility of Statistically Significant Binary Outcomes for Treating Achilles Tendinopathy: A Systematic Review of Randomized Trials | 
| title_short | The Fragility of Statistically Significant Binary Outcomes for Treating Achilles Tendinopathy: A Systematic Review of Randomized Trials | 
| title_sort | fragility of statistically significant binary outcomes for treating achilles tendinopathy a systematic review of randomized trials | 
| url | https://doi.org/10.1177/24730114241300160 | 
| work_keys_str_mv | AT omkarsanaspureba thefragilityofstatisticallysignificantbinaryoutcomesfortreatingachillestendinopathyasystematicreviewofrandomizedtrials AT shivpatelba thefragilityofstatisticallysignificantbinaryoutcomesfortreatingachillestendinopathyasystematicreviewofrandomizedtrials AT anthonynbaumanndpt thefragilityofstatisticallysignificantbinaryoutcomesfortreatingachillestendinopathyasystematicreviewofrandomizedtrials AT andrewnewsombs thefragilityofstatisticallysignificantbinaryoutcomesfortreatingachillestendinopathyasystematicreviewofrandomizedtrials AT alberttanastasiomd thefragilityofstatisticallysignificantbinaryoutcomesfortreatingachillestendinopathyasystematicreviewofrandomizedtrials AT annunziatoamendolamd thefragilityofstatisticallysignificantbinaryoutcomesfortreatingachillestendinopathyasystematicreviewofrandomizedtrials AT omkarsanaspureba fragilityofstatisticallysignificantbinaryoutcomesfortreatingachillestendinopathyasystematicreviewofrandomizedtrials AT shivpatelba fragilityofstatisticallysignificantbinaryoutcomesfortreatingachillestendinopathyasystematicreviewofrandomizedtrials AT anthonynbaumanndpt fragilityofstatisticallysignificantbinaryoutcomesfortreatingachillestendinopathyasystematicreviewofrandomizedtrials AT andrewnewsombs fragilityofstatisticallysignificantbinaryoutcomesfortreatingachillestendinopathyasystematicreviewofrandomizedtrials AT alberttanastasiomd fragilityofstatisticallysignificantbinaryoutcomesfortreatingachillestendinopathyasystematicreviewofrandomizedtrials AT annunziatoamendolamd fragilityofstatisticallysignificantbinaryoutcomesfortreatingachillestendinopathyasystematicreviewofrandomizedtrials | 
 
       